1. Home
  2. LGND vs STRA Comparison

LGND vs STRA Comparison

Compare LGND & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • STRA
  • Stock Information
  • Founded
  • LGND 1987
  • STRA 2017
  • Country
  • LGND United States
  • STRA United States
  • Employees
  • LGND 68
  • STRA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • STRA Other Consumer Services
  • Sector
  • LGND Health Care
  • STRA Real Estate
  • Exchange
  • LGND Nasdaq
  • STRA Nasdaq
  • Market Cap
  • LGND 2.2B
  • STRA 2.1B
  • IPO Year
  • LGND 1992
  • STRA 1996
  • Fundamental
  • Price
  • LGND $163.73
  • STRA $82.65
  • Analyst Decision
  • LGND Strong Buy
  • STRA Strong Buy
  • Analyst Count
  • LGND 8
  • STRA 3
  • Target Price
  • LGND $144.71
  • STRA $104.33
  • AVG Volume (30 Days)
  • LGND 139.7K
  • STRA 139.3K
  • Earning Date
  • LGND 08-05-2025
  • STRA 07-30-2025
  • Dividend Yield
  • LGND N/A
  • STRA 2.91%
  • EPS Growth
  • LGND N/A
  • STRA N/A
  • EPS
  • LGND N/A
  • STRA 4.81
  • Revenue
  • LGND $181,488,000.00
  • STRA $1,242,475,000.00
  • Revenue This Year
  • LGND $18.41
  • STRA $5.58
  • Revenue Next Year
  • LGND $18.87
  • STRA $4.11
  • P/E Ratio
  • LGND N/A
  • STRA $17.15
  • Revenue Growth
  • LGND 53.40
  • STRA 4.31
  • 52 Week Low
  • LGND $81.74
  • STRA $72.25
  • 52 Week High
  • LGND $129.90
  • STRA $104.51
  • Technical
  • Relative Strength Index (RSI)
  • LGND 74.67
  • STRA 62.99
  • Support Level
  • LGND $158.40
  • STRA $80.18
  • Resistance Level
  • LGND $161.89
  • STRA $82.10
  • Average True Range (ATR)
  • LGND 3.76
  • STRA 1.48
  • MACD
  • LGND -0.07
  • STRA 0.49
  • Stochastic Oscillator
  • LGND 93.80
  • STRA 99.82

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: